DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
复制标题
DOI:
10.3892/or.2013.2961
复制
发表时间:
2014-03
期刊:
影响因子:
4.2
通讯作者:
Zheng-ming Zhu;Zhengfeng Li;Yan Huang;Hai-Hong Yu;Xiao-shan Huang;Yu-Feng Yan;J. Shao;He-Ping Chen
中科院分区:
文献类型:
--
作者:
Zheng-ming Zhu;Zhengfeng Li;Yan Huang;Hai-Hong Yu;Xiao-shan Huang;Yu-Feng Yan;J. Shao;He-Ping Chen
Peritoneal metastasis is a major cause of death in patients with advanced gastric carcinoma. DJ-1 is now considered to play an important role in the metastasis of various malignancies. However, it remains largely unclear whether DJ-1 is involved in the development of peritoneal metastasis by gastric carcinoma. In the present study, we showed that the expression of DJ-1 was significantly upregulated in gastric cancer specimens with peritoneal metastasis compared to those without peritoneal metastasis. Knockdown of DJ-1 expression significantly inhibited invasion and migration, in vitro and the in vivo peritoneal metastatic abilities of SGC7901 gastric cancer cells. Moreover, knockdown of DJ-1 also diminished the expression of matrix metallopeptidase (MMP)-2 and MMP-9. All of these effects were reversed by restoration of DJ-1 expression. Following investigation of the pathway through which DJ-1 regulates cell invasion and migration, DJ-1 was found to cause phosphorylation of Akt in SGC7901 gastric cancer cells. Inhibition of the Akt pathway in SGC7901 cells mimicked the effects of DJ-1 knockdown on cell migration, invasion, MMP-2 and MMP-9 expression, and abolished the effects of DJ-1 in promoting SGC7901 cell invasion and migration. Taken together, the present study revealed that DJ-1 plays an important role in the development of peritoneal carcinomatosis from gastric carcinoma, at least partially through activation of the Akt pathway and consequent upregulation of MMP-2 and MMP-9 expression. Thus, DJ-1 may be a potential therapeutic target for peritoneal carcinomatosis of gastric carcinoma.